Submitted by Anonymous (not verified) on 17 April 2024 - 12:40
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 1, Status: Authorised